Significance of the number of positive lymph nodes in resected non-small cell lung cancer

Journal of Thoracic Oncology

Volumn 1, Issue 2, 2006, Pages 120-125

  Fukui, Takayuki ^a,b   Mori, Shoichi ^a   Yokoi, Kohei ^b   Mitsudomi, Tetsuya ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Single station metastasis; Skip metastasis; TNM classification

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE CLASSIFICATION; FEMALE; HAZARD RATIO; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; FOLLOW UP; LUNG RESECTION; LUNG TUMOR; LYMPHADENECTOMY; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PNEUMONECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 34247859074     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/01243894-200602000-00004     Document Type: Article

References (23)

1. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-1717.
2. Sobin LH, Wittekind Ch (Eds.). TNM classification of malignant tumors, 5th ed. New York: John Wiley & Sons, Inc. 1997.
3. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual, 6th ed. New York: Springer, 2002. Pp. 99-106.
4. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual, 6th ed. New York: Springer, 2002. Pp. 113-124.
5. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual, 6th ed. New York: Springer, 2002. Pp. 171-180.
6. Kodera Y, Yamamura Y, Shimizu Y, et al. The number of metastatic lymph nodes: A promising prognostic determinant for gastric carcinoma in the latest edition of the TNM classification. J Am Coll Surg 1998;187:597-603.
7. Ichikura T, Tomimatsu S, Uefuji K, et al. Evaluation of the New American Joint Committee on Cancer/International Union Against Cancer classification of lymph node metastasis from gastric carcinoma in comparison with the Japanese classification. Cancer 1999;86:553-558.
8. Ueda K, Kaneda Y, Sakano H, et al. Independent predictive value of the overall number of metastatic N1 and N2 stations in lung cancer. Jpn J Thorac Cardiovasc Surg 2003;51:297-301.
9. Nakata M, Saeki H, Kurita A, et al. Prognostic significance of the number of metastatic lymph nodes in surgically resected non-small cell lung cancer. Haigan 1999;39:421-427.
10. Andre F, Grunenwald D, Pignon JP, et al. Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications. J Clin Oncol 2000;18:2981-2989.
11. Yoshino I, Yokoyama H, Yano T, et al. Skip metastasis to the mediastinal lymph nodes in non-small cell lung cancer. Ann Thorac Surg 1996;62:1021-1025.
12. Yano T, Fukuyama Y, Yokoyama H, et al. Long-term survivors with pN2 non-small cell lung cancer after a complete resection with a systematic mediastinal node dissection. Eur J Cardiothorac Surg 1998;14:152-155.
13. Gunluoglu Z, Solak O, Metin M, Gurses A. The prognostic significance of skip mediastinal lymphatic metastasis in resected non-small cell lung cancer. Eur J Cardiothorac Surg 2002;21:595.
14. Prenzel KL, Monig SP, Sinning JM, et al. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer. J Surg Oncol 2003;82:256-260.
15. Sagawa M, Sakurada A, Fujimura S, et al. Five-year survivors with resected pN2 nonsmall cell lung carcinoma. Cancer 1999;85:864-868.
16. Gawrychowski J, Gabriel A, Lackowska B. Heterogeneity of stage IIIA non-small cell lung cancers (NSCLC) and evaluation of late results of surgical treatment. Eur J Surg Oncol 2003;29:178-184.
17. Misthos P, Sepsas E, Athanassiadi K, et al. Skip metastases: Analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer. Eur J Cardiothorac Surg 2004;25:502-508.
18. Riquet M, Assouad J, Bagan P, et al. Skip mediastinal lymph node metastasis and lung cancer: A particular N2 subgroup with a better prognosis. Ann Thorac Surg 2006;79:225-233.
19. Keller SM, Vangel MG, Wagner H, et al. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease. J Thorac Cardiovasc Surg 2004;128:130-137.
20. Ichinose Y, Kato H, Koike T, et al. Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: Questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trials. Lung Cancer 2001;34:29-36.
21. Bunt AM, Hogendoorn PC, van de Velde CJ, et al. Lymph node staging standards in gastric cancer. J Clin Oncol 1995;13:2309-2316.
22. Lardinois D, Suter H, Hakki H, et al. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer. Ann Thorac Surg 2006;80:268-274.
23. Gajra A, Newman N, Gamble GP, et al. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol 2003;21:1029-1034.